TLX
Telix Pharmaceuticals Ltd
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Telix Pharmaceuticals Ltd
9.09
No thesis.
Expected move
No implied move.
No implied move.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $6.5M | 17.68% | −0.63% | |
| 2 | Lazard Asset ManagementLazard | $3.3M | 8.95% | −1.97% | |
| 3 | Portland Investment CounselPortland | $3.1M | 8.38% | 0.00% | |
| 4 | Private Advisor GroupPrivate Advisor | $2.3M | 6.21% | +13.09% | |
| 5 | Marshall WaceMarshall Wace | $2.2M | 5.96% | new | |
| 6 | Morgan StanleyMorgan Stanley | $1.9M | 5.23% | +42.54% | |
| 7 | Integrated Wealth ConceptsIntegrated Wealth Concepts | $1.9M | 5.18% | 0.00% | |
| 8 | Hennion & Walsh Asset ManagementHennion & Walsh | $1.7M | 4.73% | new | |
| 9 | UBS GroupUBS | $1.6M | 4.24% | +317.02% | |
| 10 | Blair WilliamBlair William | $1.4M | 3.87% | new | |
| 11 | Raiffeisen Bank InternationalRaiffeisen Bank International | $1.3M | 3.55% | −11.54% | |
| 12 | Quadrature CapitalQuadrature Capital | $1.2M | 3.23% | new | |
| 13 | JPMorgan ChaseJPMorgan Chase | $876,185 | 2.39% | +35.21% | |
| 14 | XY CapitalXY Capital | $821,985 | 2.25% | +467.97% | |
| 15 | XTX TopcoXTX Topco | $792,987 | 2.17% | +164.45% | |
| 16 | JustInvestJustInvest | $680,143 | 1.86% | +77.39% | |
| 17 | NLB Skladi, upravljanje premozenja, d.o.o.NLB Skladi, upravljanje premozenja, d.o.o. | $668,740 | 1.83% | new | |
| 18 | Mariner Wealth AdvisorsMariner Wealth | $427,593 | 1.17% | −14.64% | |
| 19 | Capricorn Fund ManagersCapricorn Fund Managers | $416,233 | 1.14% | new | |
| 20 | GTS SecuritiesGTS Securities | $409,742 | 1.12% | new | |
| 21 | Jane Street GroupJane Street | $384,975 | 1.05% | new | |
| 22 | IHT Wealth ManagementIHT Wealth | $372,366 | 1.02% | +29.00% | |
| 23 | SummitTX CapitalSummitTX Capital | $364,590 | 1.00% | new | |
| 24 | HRT FinancialHRT Financial | $296,000 | 0.81% | new | |
| 25 | Portolan Capital ManagementPortolan | $293,139 | 0.80% | −95.30% |
61 managers report $36.6M of Telix Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; FMR is largest at 17.68%.
News
Linked news
News